CASE COMMENTS: ANTICOMPETITIVE PRACTICES - DISCRIMINATORY PRACTICES - ABUSE OF DOMINANCE -REFUSAL TO CONTRACT PHARMACEUTICAL SECTOR

Discriminatory practices: The Competition Council refuses to recognize the alleged anticompetitive practices in the pharmaceutical sector

KEYWORDS
Reference

Conseil de la concurrence, 5 octobre 2005, n° 05-D-52, relative à des pratiques mises en œuvre par des laboratoires pharmaceutiques

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. Decision No. 05-D-52 of 5 October 2005 will also be issued, ending there. again, by dismissing the proceedings on the basis of Article L. 464-6 of the French Commercial Code. In the present case, three cases had been joined.

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

This document is protected by copyright laws and international copyright treaties. Non-authorised use of this document constitutes a violation of the publisher's rights and may be punished by up to 3 years imprisonment and up to a € 300 000 fine (Art. L 335-2 Code de la Propriété Intellectuelle). Personal use of this document is authorised within the limits of Art. L 122-5 CPI and DRM protection.

PDF Version

Author

  • L’actu-concurrence (Paris)
    France 4520 contributions 1117612 visits

Quotation

Alain Ronzano, Discriminatory practices: The Competition Council refuses to recognize the alleged anticompetitive practices in the pharmaceutical sector, 5 October 2005, Concurrences N° 1-2006, Art. N° 54585, www.concurrences.com

Visites 85

All reviews